Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

PULM stock hub

Pulmatrix, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

PULMis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
4.7M
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
PULM
In the news

Latest news · PULM

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 18.4P75 33.1
Trailing P/En/a
P25 14.9P50 23.2P75 38.5
ROE-80.9
P25 -105.6P50 -46.5P75 -3.1
ROIC-50.6
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All PULM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
165
Groups with data
11
Currency
USD
Showing 165 of 165 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

23
MetricValue
Cik
0001574235
Company name
Pulmatrix, Inc.
Country
United States
Country code
US
Cusip
74584P301
Employees
2
Employees Change
-20%
Employees Change Percent
-90.91
Enterprise value
$649,379
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Biotechnology
Isin
US74584P3010
Last refreshed
2026-05-10
Market cap
$4.7M
Market cap category
Nano-Cap
Price
$1.3
Price currency
USD
Sector
Healthcare
Sic
2834
Symbol
PULM
Website
https://www.pulmatrix.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

3
MetricValue
Earnings Yield
-108.96%
FCF yield
-114.68%
P/B ratio
1.24x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

11
MetricValue
Gross Profit
$-38,000
Net Income
$-5.2M
Net Income Growth Quarters
3%
Net Income Growth Years
4%
Profit Per Employee
$-2.6M
ROA
-45.88
Roa5y
-27.19
ROCE
-135.7
ROE
-80.93
Roe5y
-62.9
ROIC
-50.65

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

7
MetricValue
Cagr10y
-44.87%
Cagr1y
-79.4%
Cagr3y
-24.34%
Cagr5y
-40.83%
EPS Growth Quarters
3
EPS Growth Years
11
Revenue Growth Years
0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

15
MetricValue
Assets
$4.1M
Cash
$4.1M
Current Assets
$4.1M
Current Liabilities
$329,000
Equity
$3.8M
Liabilities
$329,000
Long Term Assets
$10,000
Long Term Liabilities
$0
Net Cash
$4.1M
Net Cash By Market Cap
$86.29
Net Cash Growth
-57.06%
Net Debt Equity
$-1.07
Tangible Book Value
$3.8M
Tangible Book Value Per Share
$1.04
WACC
14.92

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
12.55
Net Working Capital
$-288,000
Quick ratio
12.43
Working Capital
$3.8M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
10Y total return
-99.74%
1Y total return
-79.38%
200-day SMA
3.48
3Y total return
-56.69%
50-day SMA
1.64
50-day SMA vs 200-day SMA
50under200
5Y total return
-92.74%
All Time High
2,910
All Time High Change
-99.96%
All Time High Date
2015-06-16
All Time Low
1.16
All Time Low Change
11.82%
All Time Low Date
2026-04-13
ATR
0.11
Beta
1.94
Beta1y
1.15
Beta2y
-0.33
Ch YTD
-41.83
High
1.34
High52
9.37
High52 Date
2025-05-29
High52ch
-86.16%
Low
1.28
Low52
1.16
Low52 Date
2026-04-13
Low52ch
11.82%
Ma50ch
-20.81%
Price vs 200-day SMA
-62.72%
RSI
40.67
RSI Monthly
34.93
RSI Weekly
31.45
Sharpe ratio
-1.29x
Sortino ratio
-1.51
Tr YTD
-41.83
Tr1m
2.94%
Tr1w
0.55%
Tr3m
-47.7%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

1
MetricValue
Operating Income
$-5.2M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

9
MetricValue
Float
3,652,260%
Float Percent
100%
Shares Insiders
0%
Shares Institutions
9.2%
Shares Out
3,652,285
Shares Qo Q
0%
Short Float
0.54%
Short Ratio
0.28
Short Shares
0.54

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

54
MetricValue
Adjusted FCF
$-5.5M
Average Volume
31,385.45x
Bv Per Share
1.04
Ch10y
-99.74
Ch1m
2.94
Ch1w
0.55
Ch1y
-79.38
Ch3m
-47.7
Ch3y
-56.69
Ch5y
-92.74
Ch6m
-73.26
Change
-0.22%
Change From Open
-0.22
Close
1.3
Days Gap
0
Depreciation Amortization
106,000
Dollar Volume
13,152.6
Earnings Date
2026-05-22
Earnings Time
bmo
EBIT
$-5.2M
EBITDA
$-5.1M
EPS
$-1.41
F Score
1
FCF
$-5.4M
FCF EV Yield
-836.65x
FCF Per Share
$-1.49
Fiscal Year End
December
Founded
2,003
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-02-26
Last Report Date
2025-12-31
Last Split Date
2022-03-01
Last Split Type
Reverse
Last10k Filing Date
2026-02-26
Ma150
2.99
Ma150ch
-56.59%
Ma20
1.31
Ma20ch
-0.68%
Net CF
-5,433,000
Next Earnings Date
2026-05-22
Open
1.3
Optionable
No
Position In Range
31.09
Post Close
1.3
Postmarket Change Percent
-0.55
Postmarket Price
$1.29
Price Date
2026-05-08
Ptbv Ratio
1.24
Relative Volume
0.32x
Share Based Comp
25,000
Tr6m
-73.26%
Us State
Massachusetts
Volume
10,140
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does PULM pay a dividend?

Capital-return profile for this ticker.

Performance

PULM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-79.4%
S&P 500 1Y: n/a
3Y total return
-56.7%
S&P 500 3Y: n/a
5Y total return
-92.7%
S&P 500 5Y: n/a
10Y total return
-99.7%
S&P 500 10Y: n/a
Ownership

Who owns PULM?

Insider, institutional, and short-interest positioning.

Institutional ownership
+9.2%
Float: +100.0% of shares outstanding
Insider ownership
+0.0%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+0.5%
0.3 days to cover
Y/Y dilution
n/a
Negative means the company is buying back shares.
Technical

PULM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
40.7
Neutral momentum band
Price vs 200-day MA
-62.7%
50/200-day relationship not available
Beta (5Y)
1.94
More volatile than the market
Sharpe ratio
-1.29
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About PULM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current PULM stock rating?

Pulmatrix, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full PULM analysis?

The full report lives at /stocks/PULM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for PULM?

The latest report frames PULM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the PULM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.